Literature DB >> 22104678

Prognostic significance of using solid versus whole tumor size on high-resolution computed tomography for predicting pathologic malignant grade of tumors in clinical stage IA lung adenocarcinoma: a multicenter study.

Yasuhiro Tsutani1, Yoshihiro Miyata, Haruhiko Nakayama, Sakae Okumura, Shuji Adachi, Masahiro Yoshimura, Morihito Okada.   

Abstract

OBJECTIVES: The present multicenter study compared the usefulness of the solid tumor size with that of the whole tumor size on preoperative high-resolution computed tomography for predicting pathologic high-grade malignancy (positive lymphatic, vascular, or pleural invasion) and the prognosis of clinical stage IA lung adenocarcinoma.
METHODS: We performed high-resolution computed tomography and F-18 fluorodeoxyglucose-positron emission tomography/computed tomography before curative surgical resection in 502 patients with clinical stage IA lung adenocarcinoma. The revised maximum standardized uptake values on F-18 fluorodeoxyglucose-positron emission tomography/computed tomography were used to correct interinstitutional discrepancies. The whole and solid tumor sizes on high-resolution computed tomography were then analyzed in relation to surgical results.
RESULTS: The mean whole and solid tumor size was 1.97 ± 0.59 cm and 1.20 ± 0.88 cm, respectively. The receiver operating characteristics area under the curve for the whole and solid tumor sizes used to identify high-grade malignancy were 0.590 and 0.829, respectively. Multiple logistic regression analyses demonstrated solid tumor size (P < .001) and maximum standardized uptake values of the tumor (P < .001) as independent variables for the prediction of high-grade malignancy. Multivariate Cox analysis of disease-free survival demonstrated the former (hazard ratio, 2.30; 95% confidence interval, 1.46-3.63; P < .001) and latter (hazard ratio, 1.08; 95% confidence interval, 1.00-1.17; P = .05) as independent prognostic factors.
CONCLUSIONS: The solid tumor size on high-resolution computed tomography and maximum standardized uptake values on positron emission tomography/computed tomography have greater predictive value for high-grade malignancy and prognosis in clinical stage IA lung adenocarcinoma than that of whole tumor size. Copyright Â
© 2012 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22104678     DOI: 10.1016/j.jtcvs.2011.10.037

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  60 in total

1.  The Role of Extent of Surgical Resection and Lymph Node Assessment for Clinical Stage I Pulmonary Lepidic Adenocarcinoma: An Analysis of 1991 Patients.

Authors:  Morgan L Cox; Chi-Fu Jeffrey Yang; Paul J Speicher; Kevin L Anderson; Zachary W Fitch; Lin Gu; Robert Patrick Davis; Xiaofei Wang; Thomas A D'Amico; Matthew G Hartwig; David H Harpole; Mark F Berry
Journal:  J Thorac Oncol       Date:  2017-01-08       Impact factor: 15.609

Review 2.  Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy.

Authors:  Hyungjin Kim; Chang Min Park; Jae Moon Koh; Sang Min Lee; Jin Mo Goo
Journal:  Diagn Interv Radiol       Date:  2014 Jan-Feb       Impact factor: 2.630

3.  The indication of completion lobectomy for lung adenocarcinoma ≤3 cm after wedge resection during surgical operation.

Authors:  Yiyang Wang; Rui Wang; Difan Zheng; Baohui Han; Jie Zhang; Heng Zhao; Jizhuang Luo; Jiajie Zheng; Tianxiang Chen; Qingyuan Huang; Yihua Sun; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2017-06-14       Impact factor: 4.553

4.  What could be the key elements to determine the optimal number of lymph nodes sampled?

Authors:  Yoshihisa Shimada
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

5.  Recommendations from the European Society of Thoracic Surgeons (ESTS) regarding computed tomography screening for lung cancer in Europe.

Authors:  Jesper Holst Pedersen; Witold Rzyman; Giulia Veronesi; Thomas A D'Amico; Paul Van Schil; Laureano Molins; Gilbert Massard; Gaetano Rocco
Journal:  Eur J Cardiothorac Surg       Date:  2017-03-01       Impact factor: 4.191

6.  Neither the maximum tumor size nor solid component size is prognostic in part-solid lung cancer: to be ground-glass opacity or not to be, is that really the question?

Authors:  Kimihiro Shimizu; Yoichi Ohtaki; Seshiru Nakazawa; Akira Mogi; Hiroyuki Kuwano
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

7.  Adenocarcinoma containing lepidic growth.

Authors:  Hisashi Iwata
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

8.  Long-term outcomes of open and video-assisted thoracoscopic lung lobectomy for the treatment of early stage non-small cell lung cancer are similar: a propensity-matched study.

Authors:  Tomohiro Murakawa; Junji Ichinose; Haruaki Hino; Kentaro Kitano; Chihiro Konoeda; Jun Nakajima
Journal:  World J Surg       Date:  2015-05       Impact factor: 3.352

9.  Is volumetric 3-dimensional computed tomography useful to predict histological tumour invasiveness? Analysis of 211 lesions of cT1N0M0 lung adenocarcinoma.

Authors:  Kei Shikuma; Toshi Menju; Fengshi Chen; Takeshi Kubo; Shigeo Muro; Shinji Sumiyoshi; Keiji Ohata; Terumasa Sowa; Takao Nakanishi; Hiroyuki Cho; Shinya Neri; Akihiro Aoyama; Toshihiko Sato; Makoto Sonobe; Hiroshi Date
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-02-25

10.  Evidence based imaging strategies for solitary pulmonary nodule.

Authors:  Yi-Xiang J Wang; Jing-Shan Gong; Kenji Suzuki; Sameh K Morcos
Journal:  J Thorac Dis       Date:  2014-07       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.